Bausch Health Companies (NYSE:BHC) announces that it plans to pay down an additional $100M of its outstanding secured term loans this week from cash generated from operations.
After the payment, it will have satisfied all mandatory amortization through Q2 2020.
Shares are up 2% premarket on light volume, stoked, in part, by the Mylan/Pfizer deal.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.